Licitra LF - Search Results

1

Salivary gland cancers in elderly patients: challenges and therapeutic strategies.

Colombo E, Van Lierde C, Zlate A, Jensen A, Gatta G, Didonè F, Licitra LF, Grégoire V, Vander Poorten V, Locati LD. Colombo E, et al. Among authors: licitra lf. Front Oncol. 2022 Nov 25;12:1032471. doi: 10.3389/fonc.2022.1032471. eCollection 2022. Front Oncol. 2022. PMID: 36505842 Free PMC article. Review.

2

Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients.

Licitra L, Cavina R, Grandi C, Palma SD, Guzzo M, Demicheli R, Molinari R. Licitra L, et al. Ann Oncol. 1996 Aug;7(6):640-2. doi: 10.1093/oxfordjournals.annonc.a010684. Ann Oncol. 1996. PMID: 8879381 Free article. Clinical Trial.

3

Primary high-grade mucoepidermoid carcinoma of the minor salivary glands with cutaneous metastases at diagnosis.

Locati LD, Quattrone P, Pizzi N, Fior A, Cantù G, Licitra L. Locati LD, et al. Oral Oncol. 2002 Jun;38(4):401-4. doi: 10.1016/s1368-8375(01)00082-3. Oral Oncol. 2002. PMID: 12076708

4

Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer.

Licitra L, Locati LD, Cavina R, Garassino I, Mattavelli F, Pizzi N, Quattrone P, Valagussa P, Gianni L, Bonadonna G, Solero CL, Cantu G. Licitra L, et al. Ann Oncol. 2003 Mar;14(3):367-72. doi: 10.1093/annonc/mdg113. Ann Oncol. 2003. PMID: 12598339 Free article. Clinical Trial.

5

A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid gland.

Locati LD, Quattrone P, Bossi P, Marchianò AV, Cantù G, Licitra L. Locati LD, et al. Ann Oncol. 2003 Aug;14(8):1327-8. doi: 10.1093/annonc/mdg331. Ann Oncol. 2003. PMID: 12881399 Free article. No abstract available.

6

Head and neck cancer.

Licitra L, Locati LD, Bossi P. Licitra L, et al. Ann Oncol. 2004;15 Suppl 4:iv267-73. doi: 10.1093/annonc/mdh937. Ann Oncol. 2004. PMID: 15477319 Free article. Review. No abstract available.

7

Herceptin plus chemotherapy in relapsed and/or metastatic salivary gland cancer.

Locati LD, Rinaldi G, Bossi P, Dagrada GP, Quattrone P, Cantú G, Licitra L. Locati LD, et al. Oral Oncol. 2005 Jan;41(1):97-8. doi: 10.1016/j.oraloncology.2004.03.002. Oral Oncol. 2005. PMID: 15598592 No abstract available.

8

Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinoma.

Licitra L, Suardi S, Bossi P, Locati LD, Mariani L, Quattrone P, Lo Vullo S, Oggionni M, Olmi P, Cantù G, Pierotti MA, Pilotti S. Licitra L, et al. J Clin Oncol. 2004 Dec 15;22(24):4901-6. doi: 10.1200/JCO.2004.05.071. J Clin Oncol. 2004. PMID: 15611505 Clinical Trial.

9

Adenocarcinoma of ethmoid sinus: an occupational disease.

Bimbi G, Saraceno MS, Riccio S, Gatta G, Licitra L, Cantù G. Bimbi G, et al. Acta Otorhinolaryngol Ital. 2004 Aug;24(4):199-203. Acta Otorhinolaryngol Ital. 2004. PMID: 15688904 Free article.

10

Biological agents in head and neck cancer.

Licitra L, Locati L, Bossi P. Licitra L, et al. Ann Oncol. 2006 Sep;17 Suppl 10:x45-8. doi: 10.1093/annonc/mdl235. Ann Oncol. 2006. PMID: 17018750 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page